Archive: 2021

Women in Clinical Trials for Biomedical Research | Medidata’s Diversity in Clinical Trials Series

Reading Time: 3 minutesThis blog was authored by Fiona Maini, Global Compliance and Strategy principal, Medidata,… Read More

What’s Next for External Controls | MIT Technology Review & Medidata Solutions

Reading Time: 2 minutesWritten in partnership with MIT Technology Review   External control arms… Read More

How Mid-sized & Emerging Biopharma Sponsors Can Choose Clinical Trial Technology For Their Needs

Reading Time: 3 minutesInsights from Medidata Experts Mid-sized and emerging biopharma companies drive innovation in… Read More

How Mid-sized Biopharma Sponsors Can Leverage Medidata’s Clinical Trial Technology and Expertise

Reading Time: 3 minutesInsights from Medidata Experts Mid-sized and emerging biopharma companies drive innovation in… Read More

What My Experience in a COVID-19 Vaccine Trial Taught Me About the Need for Greater Patient Centricity

Reading Time: 5 minutesKelly McKee, Vice President of Patient Registries and Recruitment at Medidata, recently participated… Read More

FDA Approval in External Control Arms | MIT Technology Review & Medidata Solutions

Reading Time: 3 minutesWritten in partnership with MIT Technology Review   How does the U.S. Food… Read More

Site Dissatisfaction and Challenges in Clinical Trial Financial Management

Reading Time: 5 minutesThe Clinical Financial Blog was created to address the complexities that… Read More

Early Adopter Feedback Shows Value of Remote Source Document Review

Reading Time: 3 minutesMedidata Remote Source Document Review Feedback Although regulatory and industry adoption of remote… Read More